Release Date	September 30, 2024
Expiration Date	September 30, 2025
Format	Webcast
CME	1.0 Credit
CE	1.0 Contact hour

Acknowledgement

This activity is provided by Talem Health and Talem MedEd.  

  
 
This activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals, Inc.

Credit Available

• Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
• Nurses — 1.0 Contact Hour (0.75 contact hour of pharmacotherapy credit)
• Pharmacists — 1.0 Contact Hour (0.1 CEU)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience 

This activity is designed specifically for dermatologists, nurse practitioners, and physician assistants involved in the care of patients with atopic dermatitis. 

Program Overview

In recent years, improved understanding of atopic dermatitis has led to the development of novel therapies that have improved quality of life and outcomes for patients. However, management remains challenging, and dermatologists may not be aware of the latest advances in the field and how they fit into existing treatment paradigms and individualized care plans. In this CME activity, expert faculty will discuss the pathophysiology of atopic dermatitis; best practices for assessment and diagnosis; and current and emerging treatment options for individuals with moderate-to-severe disease, including biologic and small molecule therapies. Questions and lessons learned from a recent practice-based CME/CE initiative will also be shared.  

The content for this enduring activity was recorded on August 5, 2024.

Learning Objectives 

Upon completion of this activity, participants should be better able to:

• Explain the pathophysiology and immunologic factors associated with atopic dermatitis 
• Summarize the safety and efficacy data of current and emerging treatment options for atopic dermatitis 
• Apply current evidence and recommendations into individualized treatment plans for patients with atopic dermatitis 
• Integrate current guideline recommendations to screen and manage comorbidities in patients with atopic dermatitis 

Faculty

Peter A. Lio, MD
Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Founding Director  
Chicago Integrative Eczema Center
Chicago, IL

 

Elle de Moll, MD
Dermatologist
Dermatology Physicians of Connecticut
Fairfield, CT 

Joint Accreditation Statement

In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation Statement

Physician Continuing Medical Education
Talem Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.75 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

Continuing Pharmacy Education
Talem Health designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008332-0000-24-056-H01-P)
Type of Activity: Application

Disclosure of Conflicts of Interest

Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.  

All relevant financial relationships have been mitigated.   

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:  

Faculty 
Peter A. Lio, MD, disclosed the following relevant financial relationships: receipt of royalty/patent holder for Theraplex AIM; consultant/advisory board member for Alphyn Biologics, AbbVie, Inc., Almirall, Amyris, Inc., Arcutis Biotherapeutics, ASLAN Pharmaceuticals, Boston Skin Science, Bristol Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosciences, Dermavant Sciences, Inc., Eli Lilly and Company, Galderma, Janssen Pharmaceuticals, Johnson & Johnson, Kimberly-Clark Corporation, LEO Pharma, Lipidor, L’Oreal, Merck & Co., Inc., Micreos, MyOr Diagnostics, Regeneron Pharmaceuticals, Inc./Sanofi Genzyme, Sibel Health, Inc., Skinfix, Sonica, Theraplex, UCB, Unilever, Verrica Pharmaceuticals, Inc., and Yobee Care; speakers’ bureau for AbbVie, Inc., Arcutis Biotherapeutics, Eli Lilly and Company, Galderma, Hyphens Pharma, Incyte Corporation, La Roche-Posay/L’Oreal, MyOr Diagnostics, ParentMD, Pfizer, Inc., Pierre-Fabre Dermatologie, Regeneron Pharmaceuticals, Inc./Sanofi Genzyme, and Verrica Pharmaceuticals; contracted research for AbbVie, Inc. and AOBiome; stock ownership interest in Codex Labs, Concerto Biosciences, and Yobee Care.  

Elle de Moll, MD, has no relevant financial relationships to disclose.  

Planners, Managers, and Reviewer  

The Talem Health planners, managers, and reviewer have nothing to disclose.  

Instructions for Participation and Credit

This activity is offered at no cost to participants. To receive CME credit, participants must: 

1. Read the CME/CE information, including learning objectives and disclosure statements. 
2. Complete the pre-test. 
3. View the online activity. 
4. Complete the post-test and evaluation form. 

A post-test score of 75% or higher is required to obtain credit. Your certificate will be made available for immediate download. 

Course Viewing Requirements 

Supported Browsers: 
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above 
Google Chrome 28.0+ for Windows, Mac OS, or Linux 
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux 
Safari 6.0+ for Mac OSX 10.7 and above 

Supported Phones & Tablets: 
Android 4.0.3 and above 
iPhone/iPad with iOS 6.1 or above 

Disclosure of Unlabeled Use 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.  

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.  

©Talem MedEd, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited. 

Media 

Internet activity 

Fee Information 

There is no fee for this educational activity. 

Contact Information 

For questions about this activity, please contact Talem MedEd (a division of Talem Health) at 800-913-9370 or cme@talemcme.com.